On this page
Carpenter syndrome
This syndrome is characterised by specific features including a malformed skull, extra fingers and toes, and sometimes developmental differences. It is present from birth and affects individuals across various populations, often requiring specialised care.
Available at Jeen Health
Clinical tests that include this
Overview
Carpenter syndrome is a rare genetic condition characterised by a combination of physical features, most notably abnormalities of the head and face, and malformations of the hands and feet [PMID:33676774]. Individuals typically have a specific skull shape called acrocephaly or oxycephaly, where the top of the head appears cone-shaped. They might also have extra fingers or toes (polydactyly) and short stature. The condition starts before birth, with many features evident at or shortly after birth. Additional features, such as possible heart problems, obesity, and developmental differences, can also be part of the syndrome.
Symptoms & clinical features
The primary clinical features of Carpenter syndrome include distinctive skull abnormalities, such as a pointed or cone-shaped head (acrocephaly) often due to the premature fusion of skull bones (craniosynostosis) [PMID:33676774]. Facial features may include a flat nasal bridge and widely spaced eyes. Hand and foot malformations are also hallmark signs, typically involving extra fingers or toes, particularly on the little finger side (postaxial polydactyly), and fusion of digits (syndactyly) [PMID:19363060]. Other common symptoms include short stature and a tendency towards obesity, which may develop during childhood. Some individuals might experience learning difficulties or developmental delay, though the severity of this can vary. Heart defects can occur in a proportion of those affected, as can umbilical hernias or other structural anomalies. Dental issues, such as missing teeth or small teeth, are also sometimes observed.
Video: Genetics 101
Affected organs
Carpenter syndrome primarily affects the skeletal system, particularly the bones of the skull, hands, and feet. Premature fusion of skull bones (craniosynostosis) can lead to an unusual head shape and may impact brain development if not managed. The extremities show characteristic malformations, with extra digits and sometimes partial fusion of fingers or toes. The heart can be affected in a subset of individuals, with various cardiac defects possibly occurring. Metabolic systems may also be involved, leading to a predisposition to obesity. In some cases, developmental differences suggest an impact on the central nervous system.
Risks & severity
The severity of Carpenter syndrome can vary widely among affected individuals. While some features, such as skull and limb malformations, are consistently present, the extent of developmental delay or the presence of heart defects can differ. Craniosynostosis, if severe, can sometimes lead to increased pressure on the brain, potentially affecting neurological development. Obesity is a common concern that can emerge in childhood, potentially leading to related health complications. Due to its rarity, the exact lifetime risks for specific secondary conditions are not well-established, but ongoing monitoring for complications such as heart problems and developmental progress is generally recommended. The condition is present from birth, and complications like respiratory infections are a common cause of health issues in early life [PMID:19363060].
Genetic causes
Carpenter syndrome is caused by pathogenic variants in the RAB23 gene [PMID:19363060]. The RAB23 gene provides instructions for making a protein that plays a role in cellular transport and signalling pathways, particularly within the primary cilium. Primary cilia are small, hair-like structures found on the surface of most cells, which act as sensory antennae for the cell, involved in crucial developmental signalling pathways. The RAB23 protein is thought to be involved in the correct functioning of these cilia. When the RAB23 gene has pathogenic variants, the protein does not function as it should, disrupting critical signalling pathways during embryonic development. This disturbance in cellular processes leads to the characteristic developmental abnormalities seen in Carpenter syndrome, particularly affecting bone formation and growth.
- RAB23 RAB23, member RAS oncogene familyThe RAB23 gene provides instructions for a protein critical in regulating intracellular transport and the hedgehog signalling pathway, important for proper embryonic development.
Inheritance pattern
Carpenter syndrome is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the altered RAB23 gene - one from each parent - to have the condition. People who have only one copy of the altered gene are known as carriers; they typically do not show symptoms of Carpenter syndrome themselves. If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two altered copies of the gene and develop Carpenter syndrome. There is a 50% chance the child will be a carrier like their parents, and a 25% chance the child will inherit two typical copies of the gene.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis of Carpenter syndrome is often initially suspected based on a child's characteristic physical features, such as craniosynostosis, specific facial features, and malformations of the fingers and toes. Imaging studies like X-rays can help confirm skeletal abnormalities. A definitive diagnosis is established through genetic testing, which can identify pathogenic variants in the RAB23 gene. In the UK, genetic testing for suspected Carpenter syndrome would typically be requested by a clinical geneticist or a paediatrician. Such testing falls under the NHS Genomic Medicine Service (GMS) pathways. For genetic testing, the relevant R-code for craniosynostosis and associated disorders, including Carpenter syndrome, would be used.
Management & lifestyle
Management of Carpenter syndrome is focused on addressing the specific symptoms and needs of each individual. This typically involves a multidisciplinary team of specialists. Surgical interventions may be required to correct craniosynostosis, often performed in infancy, to allow for proper brain growth and to improve head shape. Hand and foot malformations, such as polydactyly and syndactyly, may also be surgically corrected to improve function and appearance. Regular monitoring for potential heart defects and developmental progress is important. Individuals may benefit from paediatric follow-up for concerns such as obesity, and support for developmental or learning differences can be provided through educational and therapeutic interventions. Genetic counselling is an important part of care, providing families with information about the condition, its inheritance, and reproductive options. All management should be guided by specialists within the NHS framework, tailored to the individual's specific presentation.
UK care pathway
In the UK, if Carpenter syndrome is suspected, individuals would typically be referred to a clinical genetics service by their GP or another specialist, such as a paediatrician. This service forms part of the NHS Genomic Medicine Service (GMS). Genetic counsellors, who work alongside clinical geneticists, provide crucial support and information to families. Genetic testing, using specific R-codes for craniosynostosis syndromes or broader congenital anomaly panels, would be arranged through the GMS to confirm a diagnosis. This integrated approach ensures access to specialised care, genetic confirmation, and ongoing management planning.
Frequently asked questions
Is Carpenter syndrome something that can be cured?
Carpenter syndrome is a genetic condition, which means it is present from birth due to a change in an individual's genes. There is currently no cure for the underlying genetic cause. Management focuses on treating the specific symptoms and complications, such as surgery for skull or limb abnormalities, to improve health and quality of life.
How common is Carpenter syndrome?
Carpenter syndrome is considered a very rare condition. The exact prevalence is not well established, but only a small number of cases have been reported worldwide. Its rarity means that healthcare professionals may not encounter it frequently.
Will a person with Carpenter syndrome always have learning difficulties?
Not everyone with Carpenter syndrome will have learning difficulties or developmental delay. The presence and severity of these can vary significantly between individuals. Some individuals may experience mild learning differences, while others may have more significant developmental challenges. Regular developmental assessments are important to provide appropriate support.
What support is available for families affected by Carpenter syndrome?
Families in the UK affected by Carpenter syndrome can access support through the NHS, including clinical genetics services, paediatric specialists, and genetic counsellors. These professionals can provide information, guidance, and help coordinate care. Patient support groups and rare disease organisations can also offer valuable resources and connections with other families facing similar challenges.
Can Carpenter syndrome be detected before birth?
In some cases, certain physical features of Carpenter syndrome, such as craniosynostosis or limb abnormalities, might be observed during prenatal ultrasound scans. If such features are identified, further investigations, including prenatal genetic testing, might be offered to confirm a diagnosis before birth.
References
- Hidestrand P, Vasconez H, Cottrill C. Carpenter syndrome. The Journal of craniofacial surgery. 2009. PMID: 19165041
- Cohen MM Jr. Craniosynostosis update 1987. American journal of medical genetics. Supplement. 1988. PMID: 3144990
- Goldstone AP, Beales PL. Genetic obesity syndromes. Frontiers of hormone research. 2008. PMID: 18230893
- Hor CHH, Tang BL, Goh ELK. Rab23 and developmental disorders. Reviews in the neurosciences. 2018. PMID: 29727300
- Hasan MR, Koskenranta A, Alakurtti K. RAB23 regulates musculoskeletal development and patterning. Frontiers in cell and developmental biology. 2023. PMID: 36910145
- Singh G, Jialal I. Polyglandular Autoimmune Syndrome Type II. 2026. PMID: 30252248
- Williams C, Nocka LM, Hedger G. "Design principles of a membrane-spanning ubiquitin ligase". bioRxiv : the preprint server for biology. 2025. PMID: 41000701
- Cohen MM Jr. Hedgehog signaling update. American journal of medical genetics. Part A. 2010. PMID: 20635334